GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

Telemedicine prescriptions of semaglutide and tirzepatide, combined with a virtual behavioral program, yielded weight loss ...

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

Semaglutide shows potential for weight loss in older adults without harming bone density, but longer studies are essential to ...

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...

India’s obesity crisis is colliding with a transformative moment in treatment, as GLP-1 therapies and a key court ruling on ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...

Liraglutide - sold under the brand name Saxenda - is often offered to people with with a BMI of over 30 as it improves blood ...

In a new paper published in Clinical Nutrition, "Sarcopenic Diabetes Is an Under-Recognized and Unmet Clinical Priority," ...

The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) ...

Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.